SLC5A2 and pachyonychia congenita: Among glucose membrane transporters, several tumor cells, and particularly PC cells, have an increased expression of the SGLT2 co-transporter, and some studies concluded that SGLT2 inhibitors may have a beneficial effect in PC therapy [16,17].